Results 41 to 50 of about 171,342 (310)

Phosphatidylserine-exposing tumor-derived microparticles exacerbate coagulation and cancer cell transendothelial migration in triple-negative breast cancer

open access: yesTheranostics, 2021
Background: Neoadjuvant chemotherapy is relevant to the formation of thromboembolism and secondary neoplasms in triple-negative breast cancer (TNBC). Chemotherapy-induced breast cancer cell-derived microparticles (BCMPs) may have important thrombogenic ...
Cong Zhang   +17 more
semanticscholar   +1 more source

Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer [PDF]

open access: yesRevista Brasileira de Ginecologia e Obstetrícia
Objective Neoadjuvant chemotherapy (NACT) has become the standard of care for patients with triple-negative breast cancer (TNBC) with tumors > 1 cm or positive axillary nodes.
Maria Fernanda Imperio Pereira   +6 more
doaj   +1 more source

Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry [PDF]

open access: yes, 2013
Fixed, paraffin-embedded (FPE) tissues are a potentially rich resource for studying the role of NOTCH1 in cancer and other pathologies, but tests that reliably detect activated NOTCH1 (NICD1) in FPE samples have been lacking.
Ashworth, Todd   +29 more
core   +2 more sources

A new immunochemical strategy for triple-negative breast cancer therapy

open access: yesScientific Reports, 2021
Triple-negative breast cancer (TNBC) is a highly diverse group of malignant neoplasms which tend to have poor outcomes, and the development of new targets and strategies to treat these cancers is sorely needed.
Chih-Wei Lin   +5 more
semanticscholar   +1 more source

Constructing Ontology-Based Cancer Treatment Decision Support System with Case-Based Reasoning [PDF]

open access: yes, 2018
Decision support is a probabilistic and quantitative method designed for modeling problems in situations with ambiguity. Computer technology can be employed to provide clinical decision support and treatment recommendations.
Colloc, Joël   +4 more
core   +2 more sources

Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: clinical and immunological data of a phase I/II clinical trial [PDF]

open access: yes, 2016
Vaccination with priming and expansion of tumour reacting T cells is an important therapeutic option to be used in combination with novel checkpoint inhibitors to increase the specificity of the T cell infiltrate and the efficacy of the treatment. In
Antonilli M   +13 more
core   +1 more source

Salivary gland-type mammary carcinoma arising in microglandular adenosis: A case report and clinicopathological review of the literature

open access: yesCancer Treatment and Research Communications, 2020
Introduction: Microglandular adenosis (MGA) is a rare benign proliferative lesion lacking a myoepithelial cell layer; 27% of all reported cases have progressed to invasive carcinoma.
Victoria Rico   +8 more
doaj   +1 more source

Association Between Family History of Malignant Neoplasms and Clinicopathological Features of Breast Cancer Patients

open access: yesZhongliu Fangzhi Yanjiu, 2020
Objective To investigate the association between family history of malignant neoplasms (MN-FH) and clinicopathological characteristics of patients with breast cancer.
CAO Xinhua   +4 more
doaj   +1 more source

The neural crest transcription factor SOX 10 is preferentially expressed in triple negative breast carcinomas.

open access: yesInteramerican Journal of Health Sciences, 2021
Introduction: The expression of SOX 10 by immunohistochemistry has been documented in benign breast myoepithelial cells and in ductal carcinomas classified by the molecular subtype defined by immunohistochemistry.
A. Arra   +2 more
semanticscholar   +1 more source

Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer [PDF]

open access: yesJournal of Pathology and Translational Medicine, 2015
With the advance in personalized therapeutic strategies in patients with breast cancer, there is an increasing need for biomarker-guided therapy. Although the immunogenicity of breast cancer has not been strongly considered in research or practice, tumor-
Sung Gwe Ahn   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy